Literature DB >> 23537079

Central and peripheral expression and distribution of NUCB2/nesfatin-1.

Miriam Goebel-Stengel1, Lixin Wang.   

Abstract

Nesfatin-1 is the N-terminal fragment of nucleobindin-2 (NUCB2). The antibody against nesfatin-1 recognizes both full length of NUCB2 and nesfatin-1, thus the immunolabeling represents NUCB2/nesfatin-1. It has been found that NUCB2/nesfatin-1 is widely distributed in the rodent central nervous system. The immunoreactivity is more intensive in the brain autonomic centers that regulate feeding, neuroendocrine and cardiovascular functions, such as the hypothalamic paraventricular nucleus, supraoptic nucleus, lateral hypothalamic area, Edinger-Westphal nucleus, locus coeruleus, dorsal vagal complex and medullary raphe nuclei. In neurons, NUCB2/nesfatin-1 is located in the soma and primary dendrites, not in nerve fibers. NUCB2/nesfatin-1 is co-localized with several neurotransmitters involved in regulation of food intake, autonomic and neuroendocrine functions, including oxytocin, vasopressin, neuropeptide Y, cocaine- and amphetamine-regulated transcript, proopiomelanocortin, α-melanocyte-stimulating hormone, melanin-concentrating hormone, leptin, mammalian target of rapamycin, urocortin-1, corticotropin-releasing factor and serotonin. In the periphery, NUCB2/nesfatin-1 is located mainly in the pituitary, gastric mucosa where it coexists with ghrelin, and pancreatic endocrine cells containing insulin. Nesfatin-1 is detectable in the cerebrospinal fluid of rats. NUCB2/nesfatin-1 is measurable in the plasma, and altered under different conditions in rodents and humans, such as immune challenge, high fat diet and exercise, anorexia nervosa, anxiety and depression. Anatomical data suggest that nesfatin-1 is a unique neuroendocrine peptide that may be involved in regulation of homeostasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23537079     DOI: 10.2174/138161281939131127124814

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  20 in total

1.  24 h nesfatin-1 treatment promotes apoptosis in cardiomyocytes.

Authors:  Sandra Feijóo-Bandín; Diego Rodríguez-Penas; Vanessa García-Rúa; Ana Mosquera-Leal; Emad Abu-Assi; Manuel Portolés; Esther Roselló-Lletí; Miguel Rivera; Carlos Diéguez; José Ramón González-Juanatey; Francisca Lago
Journal:  Endocrine       Date:  2015-06-05       Impact factor: 3.633

Review 2.  Nesfatin-1 and its effects on different systems.

Authors:  C Ayada; Ü Toru; Y Korkut
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

Review 3.  Novel transmitters in brain stem vagal neurocircuitry: new players on the pitch.

Authors:  Mehmet Bülbül; R Alberto Travagli
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-29       Impact factor: 4.052

Review 4.  Neuroprotective Effects of Brain-Gut Peptides: A Potential Therapy for Parkinson's Disease.

Authors:  Dong Dong; Junxia Xie; Jun Wang
Journal:  Neurosci Bull       Date:  2019-07-08       Impact factor: 5.203

5.  Expression and function of nesfatin-1 are altered by stage of the estrous cycle.

Authors:  Alicia T Pate; Abigayle L Schnell; Teresa A Ennis; Willis K Samson; Gina L C Yosten
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-05-29       Impact factor: 3.619

6.  CRHR1 Mediates the Up-Regulation of Synapsin I Induced by Nesfatin-1 Through ERK 1/2 Signaling in SH-SY5Y Cells.

Authors:  Zheng Chen; Ya-Yun Xu; Jin-Fang Ge; Fei-Hu Chen
Journal:  Cell Mol Neurobiol       Date:  2017-06-12       Impact factor: 5.046

7.  Therapeutic Efficacy of Aerobic Exercise Training along with Oak Husk Hydroalcoholic Extract for Amelioration of Inflammation in Obese Elderly Male Mice.

Authors:  Iman Zakavi; Shila Nayebifar; Elham Ghasemi; Aliasghar Valipour
Journal:  Biomed Res Int       Date:  2021-05-03       Impact factor: 3.411

Review 8.  Peripheral signals mediate the beneficial effects of gastric surgery in obesity.

Authors:  Silvia Barja-Fernández; Cintia Folgueira; Cecilia Castelao; Rosaura Leis; Felipe F Casanueva; Luisa M Seoane
Journal:  Gastroenterol Res Pract       Date:  2015-04-15       Impact factor: 2.260

9.  Nesfatin-1 stimulates fatty-acid oxidation by activating AMP-activated protein kinase in STZ-induced type 2 diabetic mice.

Authors:  Jing Dong; Huan Xu; Huan Xu; Peng-fei Wang; Gui-ju Cai; Hai-feng Song; Chang-chen Wang; Zhao-tong Dong; Yan-jiao Ju; Zheng-yao Jiang
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

Review 10.  Nesfatin-1: role as possible new anti-obesity treatment.

Authors:  Carmine Finelli; Giuseppe Martelli; Rocco Rossano; Maria Carmela Padula; Nicolina La Sala; Luigi Sommella; Giovanni Tarantino
Journal:  EXCLI J       Date:  2014-05-26       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.